Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Medicine, Internal medicine, Blood pressure, Acute kidney injury, Atrial fibrillation, and Cardiology.
Transforming nephrology through artificial intelligence: a state-of-the-art roadmap for clinical integration
Epidemiology of sepsis-associated acute kidney injury in the ICU with contemporary consensus definitions
Systematic Review and Meta-Analysis of Machine Learning Models for Acute Kidney Injury Risk Classification
Machine learning models for acute kidney injury prediction and management: a scoping review of externally validated studies
Aspirin use and the risk for cardiovascular disease by lipoprotein(a) levels: a multi-cohort study
Epidemiological risk factors for acute kidney injury outcomes in hospitalized adult patients: a multicenter cohort study
Trends in Blood Pressure Control among US Adults With Hypertension, 2013–2014 to 2021–2023
Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical Trial
Predicted Cardiovascular Risk by the PREVENT Equations in US Adults With Stage 1 Hypertension
Trends in the Prevalence of Multiple Chronic Conditions Among US Adults With Hypertension From 1999–2000 Through 2017–2020
Biomarkers vs Machines: The Race to Predict Acute Kidney Injury
Trends in All-Cause, Cardiovascular, and Noncardiovascular Mortality Among US Adults With Hypertension
Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings
Treatment Effect Heterogeneity in Acute Kidney Injury Incidence Following Intravenous Antihypertensive Administration for Severe Blood Pressure Elevation During Hospitalization
A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes
Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial
Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit
Critical illness myopathy and trajectory of recovery in acute kidney injury requiring continuous renal replacement therapy: a prospective observational trial protocol
Multimorbidity is associated with lower total 24-hour movement activity among US adults
Correlates of Spontaneous Blood Pressure Reduction Following Severe Inpatient Hypertension Development
Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation
Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study
Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension
Association of 24-Hour Ambulatory Blood Pressure Patterns with Cognitive Function and Physical Functioning in CKD
Effect of Intensive and Standard Clinic‐Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT
Race, Sex, Age, and Regional Differences in the Association of Obstructive Sleep Apnea With Atrial Fibrillation: Reasons for Geographic and Racial Differences in Stroke Study
Impact of the SPRINT Trial on Hypertension Management
Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension